Position in TARS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$24,333,294
-$426,637 QoQ
Shares Held
386,611
+9.5% QoQ
Ownership
0.881%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. TARS ranks #67 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in TARS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,333,294 | 386,611 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $24,759,931 | 352,957 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $28,042,750 | 342,486 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $21,281,999 | 358,102 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $14,469,278 | 357,178 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $18,669,498 | 363,432 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $19,801,195 | 357,616 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $10,444,383 | 317,555 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,876,974 | 253,016 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,984,882 | 247,177 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,037,186 | 248,750 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,754,622 | 211,290 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,492,621 | 193,283 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,902,669 | 151,366 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,265,189 | 154,515 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,564,284 | 149,783 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,031,545 | 139,147 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,156,072 | 68,732 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,615,072 | 71,781 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,594,936 | 74,011 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,307,821 | 79,635 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,160,537 | 67,035 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,909,589 | 70,399 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||